Zobrazeno 1 - 10
of 14
pro vyhledávání: '"P K, Honig"'
Autor:
P K Honig
Publikováno v:
Clinical Pharmacology & Therapeutics. 91:369-372
Autor:
P K Honig
Publikováno v:
Clinical Pharmacology & Therapeutics. 95:467-469
For many years, approvals of new drugs in Japan have lagged behind those in the United States and Europe. As a result of simultaneous global development strategies, more widespread inclusion of Japan in multiregional clinical trials, and significant
Autor:
P K Honig
Publikováno v:
Clinical Pharmacology & Therapeutics. 88:155-158
Systematic reviews and meta-analyses are useful in integrating large amounts of data to inform medical practice, and it is likely that the already large number of published meta-analyses will increase further as the provisions in the Food and Drug Ad
Autor:
I. Aziz, R. Adachi, J. A. Nelson, E. R. McFadden, Brian J. Lipworth, P. K. Honig, D. A. Stempei, J. Hansen Flaschen, Louise Strauss, J. K. Jenkins, T. F. Reiss, Burton F. Dickey
Publikováno v:
New England Journal of Medicine. 339:1783-1786
Autor:
K I Kaitin, P K Honig
Publikováno v:
Clinical pharmacology and therapeutics. 94(3)
The landscape for bioinnovation is undergoing a seismic shift as drug developers, regulators, academic institutions, and government research organizations adapt to the formidable challenge of bringing new medicines to market. The inability to transla
Autor:
P K Honig
Publikováno v:
Clinical pharmacology and therapeutics. 93(6)
With increasing adoption of electronic health records (EHRs), there is an opportunity to use the free-text portion of EHRs for pharmacovigilance. We present novel methods that annotate the unstructured clinical notes and transform them into a deident
Autor:
P. K. Honig
Publikováno v:
JAMA: The Journal of the American Medical Association. 269:1513-1518
Autor:
P K Honig
Publikováno v:
Clinical Pharmacology & Therapeutics. 89:488-489
Publikováno v:
JAMA. 286(9)
Autor:
P K Honig
Publikováno v:
Clinical Pharmacology & Therapeutics. 87:628-629